Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGIntron in advanced low-grade non-Hodgkin's lymphoma
NCT00006039Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Dec 1999
- Primary completion
- Mar 2001
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon alfa in non-Hodgkin lymphoma (NHL), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Tumor Response. Started Dec 1999; status: completed.
02
Drugs
interferon alfa
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00006039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006039.